Medical News

RSS

Online training program to address the needs of autistic individuals

Continuing to be at the forefront of innovative research, education and services for individuals with developmental disabilities such as autism, the Training, Education and Research Institute (TERI), Inc. today launched a first-of-its-kind, comprehensive online training program aimed at creating a pool of Life Coaches to assist this special population and their families.

20 Oct 2009

Progressive group launches ad urging Sen. Reid to include public option in reform legislation

"The Progressive Change Campaign Committee (PCCC) launched an ad urging Sen. Harry Reid to muscle through a public option as part of healthcare reform," The Hill's Blog Briefing Room reports (Zimmerman, 10/19).

20 Oct 2009

Four Pharma companies underpay Medicaid rebate obligations, pay $124M to resolve allegations

Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals and Ortho McNeil Pharmaceutical have entered into settlement agreements for a total of $124 million to resolve claims that they violated the False Claims Act by failing to pay appropriate rebates to state Medicaid programs for drugs paid for by those programs, the Justice Department announced today.

20 Oct 2009

Humans are still evolving, says study

Although advances in medical care have improved standards of living over time, humans aren't entirely sheltered from the forces of natural selection, a new study shows.

20 Oct 2009

UT student receives fellowship grant for pre-eclampsia research

Roxanna Irani, a M.D./Ph.D. student at The University of Texas Graduate School of Biomedical Sciences at Houston (GSBS), has received a $10,000 fellowship for her efforts to better understand a condition known as pre-eclampsia that threatens the lives of expectant women and their unborn children.

20 Oct 2009

Senate postpones vote on Medicare 'doc fix'

Senate Democrats have postponed a scheduled cloture vote today on a bill that would make permanent changes to scheduled rate cuts to Medicare reimbursement for doctors and hospitals. Meanwhile, doctors worry about the cuts and lawmakers worry that the fix could break budget goals.

20 Oct 2009

New technique to treat metabolic disorders in babies while still in the womb

Researchers say a new development in cord blood transplants for inherited metabolic disorders may be curative for some babies who are treated while still in the womb.

20 Oct 2009

Health Canada issues Notice of Non-Compliance to Winston Laboratories for CIVANEX

Winston Laboratories, Inc. (“Winston Labs”), a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. today announced that it has received a Notice of Non-compliance (“NON”) from the Therapeutics Drug Directorate, Health Canada (the “Directorate”) for its New Drug Submission (NDS) for CIVANEX (zucapsaicin cream 0.075%) for the treatment of the signs and symptoms of osteoarthritis.

20 Oct 2009

Multilingual capability has a positive impact on cognitive functions

For a considerable time already there has been discussion within scientific circles about whether knowing and using multiple languages could possibly have positive effects on the human brain and thinking. There have been a number of international studies on the subject, which indicate that the ability to use more than one language brings an individual a considerable advantage.

20 Oct 2009

Diabetes represents a global health threat

The International Diabetes Federation (IDF) released new data today showing that a staggering 285 million people worldwide have diabetes.

20 Oct 2009

The CBO's educated guesses make or break reform bills

The senior Congressional Budget Office analyst whose job is calculating the costs of overhaul the health system -- an overworked, "amiable father of three" named Phil Ellis -- "is the first to admit that his painstaking numbers are almost certainly wrong," the Washington Post reports. His estimates "essentially condemned two" bills by pricing them at over a trillion, while boosting another by estimating much lower costs, illustrating the huge political stakes generated by Ellis' guesswork.

20 Oct 2009

Opinions: HIV vaccine; HIV resources help promote global disease control; U.S. fight against world hunger

Seth Berkley, president and chief executive of the International AIDS Vaccine Initiative, in a New York Times opinion piece examines how the "pessimism" over the recent controversy surrounding the results of an experimental HIV vaccine tested in Thailand "may ultimately thwart other efforts to develop an AIDS vaccine.

20 Oct 2009

Virginia Tech's College student receives EPA fellowship to study effects of mercury in toads

Christine Bergeron of Old Orchard Beach, Maine, a doctoral student in Virginia Tech's College of Natural Resources, received a fellowship from the Environmental Protection Agency's (EPA) National Center for Environmental Research for her research on the reproductive success of American toads.

20 Oct 2009

Jennerex' JX-594 granted European Orphan Drug Designation for the treatment of hepatocellular carcinoma

Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.

20 Oct 2009

Winner of first annual Healthcare Administrator Award announced

Deborah Friberg, Chief Operating Officer and Executive Vice President of WakeMed Health and Hospitals, Raleigh, North Carolina, has been named the recipient of the first annual Healthcare Administrator Award, presented by the Association for Professionals in Infection Control and Epidemiology (APIC). The award recognizes a healthcare facility's executive team member who has demonstrated significant support for infection prevention and control throughout their facility.

20 Oct 2009

Amylin Pharmaceuticals to present new data from its obesity program at Obesity 2009

Amylin Pharmaceuticals, Inc. today announced that new data from its obesity program will be presented at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society, to be held in Washington, D.C. October 24-28. Phase 2 data from the pramlintide/metreleptin combination treatment clinical program will be the subject of a late-breaking oral presentation.

20 Oct 2009

Medicare officials back away from hard line stance on insurers' warning letters

The New York Times reports: "The Obama administration on Friday backed away from an order that had prohibited insurance companies from warning Medicare recipients about the possible loss of benefits under pending legislation to overhaul the health care system." A political storm storm was triggered last month when they tried to stop such communications.

20 Oct 2009

Third-quarter financial results of Boston Scientific announced

Boston Scientific Corporation today announced financial results for the third quarter ended September 30, 2009, as well as guidance for net sales and earnings per share (EPS) for the fourth quarter and full year 2009.

20 Oct 2009

Boehringer Ingelheim's TWYNSTA approved by FDA for the treatment of hypertension

Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved TWYNSTA®, a new highly effective single pill combination therapy of telmisartan (an angiotensin receptor blocker [ARB]) and amlodipine (a calcium-channel blocker [CCB]). TWYNSTA® is indicated for the treatment of hypertension, alone or with other antihypertensive agents, and as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.

20 Oct 2009

FDA approves new oral medication for renal cell carcinoma

The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005.

20 Oct 2009

Medical News

Online training program to address the needs of autistic individuals

Progressive group launches ad urging Sen. Reid to include public option in reform legislation

Four Pharma companies underpay Medicaid rebate obligations, pay $124M to resolve allegations

Humans are still evolving, says study

UT student receives fellowship grant for pre-eclampsia research

Senate postpones vote on Medicare 'doc fix'

New technique to treat metabolic disorders in babies while still in the womb

Health Canada issues Notice of Non-Compliance to Winston Laboratories for CIVANEX

Multilingual capability has a positive impact on cognitive functions

Diabetes represents a global health threat

The CBO's educated guesses make or break reform bills

Opinions: HIV vaccine; HIV resources help promote global disease control; U.S. fight against world hunger

Virginia Tech's College student receives EPA fellowship to study effects of mercury in toads

Jennerex' JX-594 granted European Orphan Drug Designation for the treatment of hepatocellular carcinoma

Winner of first annual Healthcare Administrator Award announced

Amylin Pharmaceuticals to present new data from its obesity program at Obesity 2009

Medicare officials back away from hard line stance on insurers' warning letters

Third-quarter financial results of Boston Scientific announced

Boehringer Ingelheim's TWYNSTA approved by FDA for the treatment of hypertension

FDA approves new oral medication for renal cell carcinoma

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News